SEHK:3933Pharmaceuticals
United Laboratories International Holdings (SEHK:3933) Margin Compression Challenges Bullish Narrative
How United Laboratories International Holdings' Latest Numbers Set the Stage for the Narrative
United Laboratories International Holdings (SEHK:3933) has put up a busy FY 2025 first half, with revenue of about C¥7.5b and basic EPS of C¥1.04 sitting against trailing twelve month revenue of roughly C¥14.1b and basic EPS of C¥1.69. Investors are sifting through what the shift in earnings power really means. Over the last three reported half year periods, revenue has moved from C¥7.2b in 1H 2024...